EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces that it will report financial results for the three and six months ended June 30, 2023 after market close on Thursday, August 10, 2023 and will hold an i…
Author: Business Wire
Veero™ Adds Segment Height to EyeSize Eyewear Fitting Solution, Provides Precise Measurements to Properly Fit Progressive Lenses
BOSTON–(BUSINESS WIRE)–AI-software innovator Veero™ has added a precision segment (seg) height measurement experience to its EyeSize virtual-fit solution for eyewear retailers. The new feature is a gamechanger for online sales of progressive lenses. …
Aleta Biotherapeutics Granted MHRA Clinical Trial Authorization for Biologic CAR T-Cell Engager ALETA-001
NATICK, Mass.–(BUSINESS WIRE)–Aleta Biotherapeutics (Aleta), a privately-held immuno-oncology company with a platform of CAR T-Cell Engagers (CTE) which enable cell therapies to improve outcomes for patients with cancer, announces that the U.K. Medic…
STAAR Surgical to Participate in Upcoming Investor Conferences
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that management will participate in several upcoming investor conferences. ST…
Federman & Sherwood Investigates Family Vision of Anderson, P.A. for Data Breach
OKLAHOMA CITY–(BUSINESS WIRE)– #AndersonSC–The law firm of Federman & Sherwood has initiated an investigation into Family Vision of Anderson with respect to their recent data breach. On July 26, 2023, Family Vision of Anderson notified 62,631 in…
Glaukos Announces Second Quarter 2023 Financial Results
ALISO VIEJO, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced financ…
STAAR Surgical Reports Second Quarter 2023 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023. Second Quarter 2…
LENSAR to Report Second Quarter 2023 Financial Results on Wednesday, August 9, 2023
ORLANDO, Fla.–(BUSINESS WIRE)–LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company’s sec…
Bausch + Lomb Announces Second-Quarter 2023 Results and Raises Full-Year 2023 Revenue Outlook
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation, (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its second-quarter 2023 financial results. “The second quarter wa…
Demy-Colton to Convene More than 700 BioFuturists Shaping What‘s Next in Healthcare
NEW YORK–(BUSINESS WIRE)– #biofuture2023–Join 700+ therapeutic innovators, journalists and investors Oct. 4-6 to shape the future of bioscience. Register for the BioFuture™ conference now!
US Eye Successful in Opening New Operating Room at Center For Visual Surgical Excellence
CHESAPEAKE, Va.–(BUSINESS WIRE)– #Eyecare–US Eye has opened a second ophthalmic operating room at the Center For Visual Surgical Excellence (CVSE), located in Chesapeake, VA.
AXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody Test
SAN DIEGO–(BUSINESS WIRE)–AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,” “AXIM” or “the Company”), an international healthcare diagnostic solutions development company, announced today the receipt of notification by the United States Paten…
Bausch + Lomb Solidifies Leadership Team
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced changes to its executive leadership team including the creation of…
Children’s Hospital Los Angeles Researcher to Lead First-Ever International Liquid Biopsy Retinoblastoma Study
LOS ANGELES–(BUSINESS WIRE)–Children’s Hospital Los Angeles will lead an international liquid biopsy retinoblastoma study, the first of its kind.
Three New Clinical Studies Presented at the Society of Neurointerventional Surgery Annual Meeting Further Validate Impact of Viz™ Neuro Suite
SAN FRANCISCO–(BUSINESS WIRE)– #ai–Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz Neuro Suite at the Soc…
Zenni Breaks Barriers Mainstreaming Migraine Lens Technology
NOVATO, Calif.–(BUSINESS WIRE)–Zenni, the world’s leading online eyewear retailer, today announced its latest technology innovation launch: FL-41 migraine lenses developed to help those with light sensitivity due to migraines, post-concussion relief …
Harrow Launches VIGAMOX® in the U.S.
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for VIGAMOX® (moxifloxacin hydrochloride ophth…
National Vision Announces Walmart Partnership Ending in 2024
DULUTH, Ga.–(BUSINESS WIRE)–National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”), the nation’s second largest optical retailer providing quality, affordable eye care and eyewear, today announced its partnership with Walma…
Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023
NASHVILLE, Tenn.–(BUSINESS WIRE)—- $HROW–Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it will release its financial results for the second quarter ended June 30, 2023, on Wednesday, August 9, 2023, afte…
North Georgia Eye Associates is the First to Offer Personalized Laser Cataract Surgery with ALLY® Adaptive Cataract Treatment System in Georgia
ATLANTA–(BUSINESS WIRE)–North Georgia Eye Associates is pleased to share that Dr. Jack Chapman, Dr. Matthew B. Kaufman, Dr. Jeffrey Crowder, and Dr. Matthew Hollar became the first throughout Georgia to utilize the recently FDA-cleared ALLY Adaptive …